Pasithea Therapeutics
(NASDAQ) KTTA
Pasithea Therapeutics Financials at a Glance
Market Cap
$18.06M
Revenue (TTM)
$0.00
Net Income (TTM)
$13.49M
EPS (TTM)
$-5.08
P/E Ratio
-0.15
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.79
Volume
205,108
Open
$0.77
Price
$0.79
Volume
205,108
Open
$0.77
Previous Close
$0.80
Daily Range
$0.76 - $0.81
52-Week Range
$0.28 - $3.79
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.79
Volume
205,108
Open
$0.77
Previous Close
$0.80
Daily Range
$0.76 - $0.81
52-Week Range
$0.28 - $3.79
KTTA News
KTTA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pasithea Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
4
CEO
Tiago Reis Marques, MD, PhD
Website
www.pasithea.comHeadquarters
Miami Beach, FL 33139, US
KTTA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-90%
Return on Capital
-1%
Return on Assets
-99%
Earnings Yield
-6.67%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$18.06M
Shares Outstanding
23.09M
Volume
205.11K
Short Interest
0.00%
Avg. Volume
178.54K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$14.25M
EBITDA
$13.60M
Operating Cash Flow
$13.92M
Capital Expenditure
$2.00
Free Cash Flow
$13.92M
Cash & ST Invst.
$6.92M
Total Debt
$0.00
Pasithea Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$181.54K
N/A
Gross Margin
0.00%
N/A
Market Cap
$18.06M
N/A
Market Cap/Employee
$4.51M
N/A
Employees
4
N/A
Net Income
$3.04M
-1.3%
EBITDA
$2.86M
-0.5%
Quarterly Fundamentals
Net Cash
$4.12M
-56.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-99.00%
N/A
Return on Invested Capital
-1.13%
N/A
Free Cash Flow
$2.89M
+7.4%
Operating Cash Flow
$2.89M
+7.4%